News

Investigators called for more studies which feature adequately powered trials of test-guided dietary exclusions.

The cumulative probability of death was 26% at day 7 and increased to 53% at day 21.

New data from the Liberty Asthma VOYAGE study saw fewer asthma exacerbations and improved lung function in this patient population.

The topical drug was associated with adverse events that were mainly localized to the application site and mild to moderate in nature.

The US recommended HBV vaccines to be part of the infant immunization plan in 1991.

The first approval for the novel device was met with acclaim in the field this year. Now, specialists want to see how their colleagues will implement it.

In a recent clinical trial, Evusheld recipients at increased risk of severe COVID-19 infection saw a 77% reduced risk of developing COVID-19.

Donald Alcendor, PhD, joins to review currently available data surrounding the newest COVID-19 variant of concern, and shares guidance for concerned clinicians and the general public.

Investigators detail the clinical criteria of the condition and speak to the safety of the COVID-19 vaccine for this patient population.

The condition is rare, with limited epidemiological data and no standard treatment.

Investigators found about 70% of rheumatology patients had a good antibody response to the COVID-19 vaccines.

The meta-analysis showed a mean improvement of 15.7 ETDRS letters and central retinal thickness of 269.7 μm at 12 months.

The rigidity of hospital settings and a lack of awareness prevents better hepatitis C virus diagnoses in the homeless population.

According to investigators, no previous studies had investigated the expression of IL-38 in patients with vitiligo.

Investigators suggested that peer-led asthma program implemented in venues such as schools, houses of worship, or clinics can improve access to asthma education.

Bincy Abraham, MD, led the State of Science program on C difficile infections.

The treatment also has potential in Crohn's disease and rheumatoid arthritis.

Fish oil intervention and DASH diet show no statistically significant effect on glycemic control and adiposity.

Several different cardiovascular symptoms have presented in patients with COVID-19.

A litany of research has begun to shape the potential benefit of UV treatment for the skin disorder. Experts share what more needs to be known.

Circadian disruption presented across a variety of high-risk, prodromal, and syndromic psychiatric disorders.

Our annual recap series will feature stories from nearly every specialty of medicine—and the return of COVID-19 as a topic.

COVID-19 mitigation measures resulted in a historically low influenza season.

The State of the Science events allows experts to come together to update on recent research for CDI.

Participants with diabetes mellitus specifically were more prone to develop insulin resistance due to BPA exposure as compared to non-diabetic participants

A case for more proactive lipid-lowering treatment initiation in a high-risk population.

Lipid testing rates are very low among those under 40 years old. Where do clinicians best target high-risk patients—and how?

Data show the relative expression of SORT1 gene was upregulated by 4.438 fold in patients with CAD, compared to control.